• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Biden Administration Announces New Cancer Research Initiative

Medically reviewed by Drugs.com.

By Steven Reinberg HealthDay Reporter

THURSDAY, July 27, 2023 -- The Biden administration on Thursday launched a new research program aimed at helping doctors to better distinguish cancer cells from healthy tissue during surgery.

The program will fall under the purview of the Advanced Research Projects Agency for Health (ARPA-H). The agency was first formed in March 2022 as part of Biden's Cancer Moonshot initiative.

"Surgical procedures are often the first treatment option for the approximately 2 million Americans diagnosed with cancer each year," the White House said in a statement announcing the new program. "However, current surgical technologies do not allow doctors to easily and fully distinguish cancer cells from normal surrounding tissue in the operating room. This can lead to repeat surgeries, a more difficult recovery, and cancer recurrence, as well as higher health care costs."

But Biden noted that new approaches are on the horizon.

"Researchers and innovators across the country are pioneering new techniques and technologies to make cancer removal surgeries more precise, accurate and achievable," Biden added in a statement. "It’s an exciting horizon in cancer research and development that could save and extend many lives. Now, through ARPA-H, we will fund promising new approaches to removing cancer surgically."

The new initiative could improve cancer treatments and lead to new breakthroughs, Arati Prabhakar, director of the White House Office of Science and Technology Policy, told the Associated Press.

"What’s true is that many cancer treatments still start with surgery," she said. "So, being really smart and attacking and developing new technology to make that first step better could really revolutionize how we are able to treat cancer for so many Americans."

Prabhakar added that usually federal research money goes to university or government labs, but ARPA programs will search more broadly.

"The mission is to reach for things that aren’t that obvious or feasible today -- and to do that, you have to take risks," Prabhakar said. "The process allows you to explore things that could have a bigger impact if they do work and very often what I have seen is that the overall program succeeds even though some of the individual pieces don’t succeed."

ARPA has placed an open call for other research objectives, Danielle Carnival, coordinator of the White House Cancer Moonshot program, told the AP. ARPA’s work is a "central pillar" of the administration's plans to meet its goal of cutting cancer deaths.

"I would expect some really great ideas and new projects to come out of that call," Carnival said.

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2023

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.